Finance
Insilico Medicine, SK Biopharmaceuticals strike $2.5B AI drug discovery deal targeting neuroimmune therapies
Image via Fortune
Article Summary
34 words
“We want to be the SpaceX of the pharmaceutical industry,” Alex Zhavoronkov, co-CEO of Insilico Medicine tells Fortune. This story was reported by Fortune. For more Finance news in Kenya, stay tuned to Masaa.
Continue Reading
Full story on Fortune
🔗 Clicking will take you to fortune.com



